NL166188B -
METHOD FOR PREPARING A SUBSTANCE-DRUGING MEDICINE, CONTAINING A PURINE-3 ', 5' -CYCLOPHOSPHATE COMPOUND, OBTAINED PREPARED MEDICINE, USING THIS PROCESS AND PROCESS-3-PROCESS -CYCLOPHOSPHATE COMPOUND, SUITABLE FOR USE IN THE SAID METHOD FOR PREPARING A MEDICINAL PRODUCT.
- Google Patents
METHOD FOR PREPARING A SUBSTANCE-DRUGING MEDICINE, CONTAINING A PURINE-3 ', 5' -CYCLOPHOSPHATE COMPOUND, OBTAINED PREPARED MEDICINE, USING THIS PROCESS AND PROCESS-3-PROCESS -CYCLOPHOSPHATE COMPOUND, SUITABLE FOR USE IN THE SAID METHOD FOR PREPARING A MEDICINAL PRODUCT.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbhfiledCriticalBoehringer Mannheim Gmbh
Publication of NL7003222ApublicationCriticalpatent/NL7003222A/xx
Publication of NL166188BpublicationCriticalpatent/NL166188B/en
Application grantedgrantedCritical
Publication of NL166188CpublicationCriticalpatent/NL166188C/en
C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
C07H19/16—Purine radicals
C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
NL7003222A1969-04-301970-03-06
METHOD FOR PREPARING A SUBSTANCE-DRUGING MEDICINE, CONTAINING A PURINE-3 ', 5' -CYCLOPHOSPHATE COMPOUND, OBTAINED PREPARED MEDICINE, USING THIS PROCESS AND PROCESS-3-PROCESS -CYCLOPHOSPHATE COMPOUND, SUITABLE FOR USE IN THE SAID METHOD FOR PREPARING A MEDICINAL PRODUCT.
NL166188C
(en)
METHOD FOR PREPARING A SUBSTANCE-DRUGING MEDICINE, CONTAINING A PURINE-3 ', 5' -CYCLOPHOSPHATE COMPOUND, OBTAINED PREPARED MEDICINE, USING THIS PROCESS AND PROCESS-3-PROCESS -CYCLOPHOSPHATE COMPOUND, SUITABLE FOR USE IN THE SAID METHOD FOR PREPARING A MEDICINAL PRODUCT.
PROCESS FOR THE PREPARATION OF A 15-DEOXY-16-OXYGENATED PROSTIC ACID DERIVATIVES, CONTAINING MEDICINAL PRODUCT WITH ANTI-BODY SAPAPERATING EFFECT AND FOR A PROSTIC ACID DERIVATIVE, SUITABLE FOR USE IN THIS PROCESS
METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH BLOOD PRESSURE-REDUCING ACTION AND METHOD FOR PREPARING A COMPOUND SUITABLE FOR USE IN THE FOREGOING PROCESS
PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH (BETA) ADDRENERGIC BLOCKING ACTION, FORMED MEDICINAL PRODUCT OBTAINED UNDER APPLICATION THEREOF, AND PROCESS FOR PREPARING A COMPOUND SUITABLE FOR USE FOR USE.
METHOD FOR PREPARING A SUBSTANCE-DRUGING MEDICINE, CONTAINING A PURINE-3 ', 5' -CYCLOPHOSPHATE COMPOUND, OBTAINED PREPARED MEDICINE, USING THIS PROCESS AND PROCESS-3-PROCESS -CYCLOPHOSPHATE COMPOUND, SUITABLE FOR USE IN THE SAID METHOD FOR PREPARING A MEDICINAL PRODUCT.
PROCESS FOR PREPARING A MEDICINAL PRODUCT AND FORMED MEDICINAL PRODUCTS OBTAINED UNDER APPLICATION, AND A PROCESS FOR PREPARING A COMPOUND SUITABLE FOR USE IN THE SAID PROCEDURE.
METHOD OF PREPARING A MEDICINAL PRODUCT WITH A 5-HYDROXYTRYPTAMINE ANTAGONATING ACTION AND THE OBTAINED PREPARED MEDICINAL PRODUCT, AND A PROCESS FOR PREPARING A MEDICINAL PRODUCT FOR RECORDING IN SUCH A MEDICINAL MEDICINAL PRODUCT.
PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION CONTAINING A 4-OXAZOLINE-2-ON-DERIVATIVE, PREPARATION AND PROCEDURE FOR PREPARING A COMPOUND SUITABLE FOR USE IN THE SAID PROCESS.
METHOD OF PREPARING A MEDICINAL PRODUCT FOR HEART DISEASES AND THE OBTAINED PREPARED MEDICINAL PRODUCT AND FOR PREPARING A PROCESS SUITABLE FOR INCLUDING IN SUCH MEDICINAL PRODUCT 1-AMINO-3-CHROMAN-2-AMINO-3-CHROMAN.
METHOD FOR PREPARING A MEDICINAL PRODUCT WITH BETA-ADRENERGICLY BLOCKING ACTION USING CARBOSTYRIL DERIVATIVES, AND METHOD FOR PREPARING CARBOSTYRIL DERIVATIVES, SUITABLE FOR SUCH AMOUNT OF THE SAME
PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH BLOOD SUGAR MIRROR REDUCING ACTION, USING THIS FORMED MEDICINAL PRODUCT, AND PROCESS FOR PREPARING A COMPOUND SUITABLE FOR USE IN THE FOREGOING.
PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION, BASED ON AN ALFA-CINNAMYLIDEENAMINO-GUANIDINE, THE PREPARED PRODUCT USING THIS PROCESS, AMENDOUS AMINO-PROCIDE AND PROTEIN IN THE SAID METHOD.
PROCESS FOR PREPARING A PHOSPHORYLASE AND LIPOLYSE PREPARATION CONTAINING A PURINERIBONUCLEOSIDE-3 ', 5'-CYCLO-PHOSPHATE SUBSTITUTED IN THE 6-PLACE AND PREVENTED FROM THE PROCESS PREVENTED THEREFORE PREPARED FOR THIS PROCEDURE PURINERIBONUCLEOSIDE-3 ', 5'-CYCLOPHOSPHATES.
PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS BASED ON A 5-Substituted-5-FENYLALKYLBARBITUURZUURDERIVAAT, AND METHOD FOR PRODUCING 5-Substituted-5-FENYLALKYLBARBITUURZUURDERIVATEN, SUITABLE FOR USE IN SUCH PREPARATIONS.
PROCEDURE FOR PREPARING A MEDICINAL PRODUCT WITH SPASMOLYTIC ACTION AND THE MEDICINAL PRODUCT THEREFORE OBTAINED, AND A PROCESS FOR PREPARING A FENYLAZERA FENYLAZENIDURE SUITABLE FOR INCLUSION IN SUCH MEDICINAL FENYLAZER FENYLAZIN.
PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT CONTAINING A (1-CYCLOHEXEN-1-YL) ACETIC ACID DERIVATIVE AND THE MEDICINAL PRODUCT THEREFORE OBTAINED, AND PROCESS FOR PREPARING A SUGGESTED CYCLES 1 ACETIC ACID DERIVATIVE.
PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION EFFECTIVE AGAINST LIVER DISEASE, PREPARATION PREPARED USING THIS PROCESS, AND PROCEDURE FOR PREPARING THE ACTIVE COMPONENT OF THE RELATED MEDICINAL PRODUCT.